Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank86
3Y CAGR+37.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+37.4%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.11M | -3.4% |
| 2024 | $3.22M | -18.9% |
| 2023 | $3.97M | +231.5% |
| 2022 | $1.20M | +112.4% |
| 2021 | $564000.00 | +355.2% |
| 2020 | $-221000.00 | -183.6% |
| 2019 | $264335.00 | +464.8% |
| 2018 | $-72453.00 | -110.5% |
| 2017 | $689053.00 | -26.8% |
| 2016 | $941892.00 | - |